Methenmadinone acetate: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Methenmadinone Acetate == | |||
[[File:Methenmadinone_acetate.svg|thumb|right|Chemical structure of Methenmadinone acetate]] | |||
'''Methenmadinone acetate''' (MMA) is a synthetic [[progestin]] of the 19-norprogesterone group. It is used in [[hormonal contraception]] and [[hormone replacement therapy]]. | |||
Methenmadinone acetate | |||
== | == Chemical Structure and Properties == | ||
Methenmadinone acetate is a derivative of [[progesterone]], specifically a 19-norprogesterone. Its chemical structure is characterized by the presence of an acetate group, which enhances its [[bioavailability]] and [[pharmacokinetics]]. The molecular formula of methenmadinone acetate is C23H30O4. | |||
== Mechanism of Action == | |||
[[ | As a progestin, methenmadinone acetate acts on the [[progesterone receptor]]s in the body. It mimics the effects of natural progesterone, leading to changes in the [[endometrium]] that prevent [[ovulation]] and alter the cervical mucus to inhibit [[sperm]] penetration. | ||
[[ | |||
[[ | == Clinical Uses == | ||
[[ | |||
[[Category: | Methenmadinone acetate is primarily used in [[contraceptive]] formulations. It is also utilized in [[hormone replacement therapy]] for [[menopausal]] symptoms and in the treatment of certain [[gynecological disorders]]. | ||
[[Category: | |||
[[Category: | == Side Effects == | ||
Common side effects of methenmadinone acetate include [[nausea]], [[headache]], [[breast tenderness]], and [[mood changes]]. Long-term use may be associated with an increased risk of [[thromboembolic events]] and [[breast cancer]]. | |||
== Pharmacokinetics == | |||
Methenmadinone acetate is administered orally and is well absorbed from the [[gastrointestinal tract]]. It undergoes extensive [[hepatic metabolism]] and is excreted primarily in the urine. | |||
== Related Compounds == | |||
Methenmadinone acetate is related to other 19-norprogesterone derivatives such as [[medroxyprogesterone acetate]] and [[norethisterone]]. These compounds share similar mechanisms of action but differ in their pharmacokinetic profiles and clinical applications. | |||
== Related Pages == | |||
* [[Progestin]] | |||
* [[Hormonal contraception]] | |||
* [[Hormone replacement therapy]] | |||
* [[Progesterone]] | |||
{{Progestogens}} | |||
[[Category:Progestogens]] | |||
[[Category:Contraception]] | |||
[[Category:Hormone replacement therapy]] | |||
Latest revision as of 16:33, 16 February 2025
Methenmadinone Acetate[edit]

Methenmadinone acetate (MMA) is a synthetic progestin of the 19-norprogesterone group. It is used in hormonal contraception and hormone replacement therapy.
Chemical Structure and Properties[edit]
Methenmadinone acetate is a derivative of progesterone, specifically a 19-norprogesterone. Its chemical structure is characterized by the presence of an acetate group, which enhances its bioavailability and pharmacokinetics. The molecular formula of methenmadinone acetate is C23H30O4.
Mechanism of Action[edit]
As a progestin, methenmadinone acetate acts on the progesterone receptors in the body. It mimics the effects of natural progesterone, leading to changes in the endometrium that prevent ovulation and alter the cervical mucus to inhibit sperm penetration.
Clinical Uses[edit]
Methenmadinone acetate is primarily used in contraceptive formulations. It is also utilized in hormone replacement therapy for menopausal symptoms and in the treatment of certain gynecological disorders.
Side Effects[edit]
Common side effects of methenmadinone acetate include nausea, headache, breast tenderness, and mood changes. Long-term use may be associated with an increased risk of thromboembolic events and breast cancer.
Pharmacokinetics[edit]
Methenmadinone acetate is administered orally and is well absorbed from the gastrointestinal tract. It undergoes extensive hepatic metabolism and is excreted primarily in the urine.
Related Compounds[edit]
Methenmadinone acetate is related to other 19-norprogesterone derivatives such as medroxyprogesterone acetate and norethisterone. These compounds share similar mechanisms of action but differ in their pharmacokinetic profiles and clinical applications.
Related Pages[edit]